Particulate and soluble forms of the inducible nitric oxide synthase are distinguishable at the amino terminus in RAW 264.7 macrophage cells

Biochemical and Biophysical Research Communications
G E Ringheim, J Pan

Abstract

We report here on the characterization of soluble and particulate forms of the inducible nitric oxide synthase in RAW 264.7 macrophage cells. Stimulation of these cells with E. coli lipopolysaccharide and interferon-gamma resulted in a significant induction of nitric oxide synthase activity with approximately 20% of the total activity localized to the cell membrane. Like the soluble enzyme form, the membrane-associated nitric oxide synthase activity was inhibited by NG-monomethyl-L-arginine and did not require the addition of calcium. Both protein forms were immunoreactive on Western blots with antibodies specifically recognizing the carboxyl terminus of the protein. In contrast, antibodies specific for the amino terminus recognized inducible nitric oxide synthase from the cytosol, but failed to recognize the membrane-associated protein. Thus, macrophage cells are capable of expressing two forms of the inducible nitric oxide synthase that are definable by an intracellular distribution that correlates to antigenic differences at the amino terminus.

Citations

Oct 20, 2001·The Tohoku Journal of Experimental Medicine·T IshibashiJ Schrader
Oct 16, 2004·The Journal of Biological Chemistry·Inmaculada Navarro-LéridaIgnacio Rodríguez-Crespo
Apr 13, 2004·Journal of Cell Science·Inmaculada Navarro-LéridaIgnacio Rodríguez-Crespo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.